Understanding how tumors escape from immune attack may offer novel therapeutic opportunities. Veglia et al. (2019) demonstrate in Nature that fatty acid transport protein 2 (FATP2) endows neutrophils with immunosuppressive capabilities that promote cancer growth. This receptor can be targeted to unleash anti-tumor immunity and to potentiate immune checkpoint blockade.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccell.2019.05.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!